Strawbridge, et al reported that the polymorphism of CENTD2 was associated with fasting proinsulin levels in 10,701 nondiabetic adults of European ancestry and the proinsulin-raising allele was associated with a lower fasting glucose, improved β-cell function, and lower risk of type 2 diabetes [35]. This evidence concerns the gene ARAP1 and type 2 diabetes mellitus.